News & Updates

Use of aspirin at 100 mg per day proved unsuccessful at reducing the incidence of age-related macular degeneration (AMD) in a large cohort of older healthy individuals, according to medium-term data from the AMD substudy of the Aspirin in Reducing Events in the Elderly (ASPREE) trial.

Soft topical steroid application and standard steroid treatment demonstrate similar efficacy and safety in patients who underwent cataract surgery, reports a study.